Multicenter screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison with <scp>NICE</scp> guidelines and <scp>ACOG</scp> recommendations
N. O’Gorman(Harris Birthright Research Centre for Fetal Medicine), K. H. Nicolaides(Harris Birthright Research Centre for Fetal Medicine), Liona C. Poon(Chinese University of Hong Kong), C. de Paco Matallana(Instituto de Salud Carlos III), Daniel L. Rolnik(Monash Health), Argyro Syngelaki(University College Hospital), N. Karagiotis(Harris Birthright Research Centre for Fetal Medicine), Andrea Pazos(Instituto de Investigación Biosanitaria de Granada), George Papaioannou(University General Hospital Attikon), W. Plasencia(Hospiten Group), Alexander Frick(Harris Birthright Research Centre for Fetal Medicine), M. Fiolna(Medway Maritime Hospital), S. Mastrodima(Harris Birthright Research Centre for Fetal Medicine), D. Wright(University of Exeter), Ilma Floriana Carbone(Ospedale Maggiore), M. De Alvarado(Homerton University Hospital), V. Dütemeyer(Medizinische Hochschule Hannover)
Cited by 363
Related Papers
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
|The Lancet|2003|828
Observed to expected lung area to head circumference ratio in the prediction of survival in fetuses with isolated diaphragmatic hernia
|Ultrasound in Obstetrics and Gynecology|2007|623
ASPRE trial: performance of screening for preterm pre‐eclampsia
|Ultrasound in Obstetrics and Gynecology|2017|455
Severe diaphragmatic hernia treated by fetal endoscopic tracheal occlusion
|Ultrasound in Obstetrics and Gynecology|2009|424